We are collaborating with other industry partners and two local medical centers to provide personalized health care to both adults and newborns in Taiwan. We are providing comprehensive insights into preventable, actionable disease caused by genetic variance to the people of Taiwan.
We target 18~36 years old adults and provide them with health management reports based on WGS and tailored analysis for Ethnic Chinese, so the people in Taiwan can manage their health and take action early.
We are developing WGS-based newborn screening that provides better health related insights for both newborns and parents. This will also help to improve public health in Taiwan.
CDC Tier 1
Familial hypercholesterolemia, Lynch Syndrome, Hereditary Breast and Ovarian Cancer
ACMG (81 genes)
Fabry Disease, CADASIL,
PCA, Hearing Impairment
Anticancer Medication, Immunosuppressive Drug, NSAID, Proton-pump Inhibitor, Antidepressant, Statin Medication, Anticonvulsant
We are looking for partners worldwide to improve public health together!
Copyright © 2024 pdc4pm — All right reserved